Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Wells Hb"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dignan, MB, Michielutte, R, Wells, HB, Sharp, P, Blinson, K, Case, LD, Bell, R, Konen, J, Davis, S, McQuellon, RP
Publikováno v:
Health Education Research; Dec1998, Vol. 13 Issue 4, p545, 12p
Autor:
Dignan M, Michielutte R, Blinson K, Wells HB, Case LD, Sharp P, Davis S, Konen J, McQuellon RP, Dignan, M, Michielutte, R, Blinson, K, Wells, H B, Case, L D, Sharp, P, Davis, S, Konen, J, McQuellon, R P
Publikováno v:
JNCI: Journal of the National Cancer Institute; 11/20/96, Vol. 88 Issue 22, p1670-1676, 7p
Publikováno v:
Health Education Research; Dec1994, Vol. 9 Issue 4, p411-420, 10p
Publikováno v:
Health Education Research; Dec1994, Vol. 9 Issue 4, p421-432, 12p
Autor:
Cooper Mr, Julia M. Cruz, Eugene H. Paschold, Richard M. Christian, Robert L. Capizzi, Bayard L. Powell, Hyman B. Muss, W R Black, Wells Hb, Don V. Jackson
Publikováno v:
Journal of Clinical Oncology. 6:1098-1106
One hundred thirty-eight patients with recurrent or metastatic breast cancer were randomized to receive megestrol acetate 40 mg orally four times daily or tamoxifen 10 mg orally twice a day. Upon treatment failure patients were crossed over to the al
Autor:
Hyman B. Muss, E K Pope, Richards F nd, Douglas R. White, Charles L. Spurr, John J. Stuart, Cooper Mr, Wells Hb, Don V. Jackson
Publikováno v:
American journal of clinical oncology. 6(3)
Due to a recent alarming report suggesting that the severe neurotoxicity observed following treatment with a multiagent chemotherapy regimen might be due to the interaction of vincristine and VP-16-213, the neurologic toxicity data from a randomized
Autor:
Edward J. Modest, Meredith W, V S Sethi, Barringer Ml, Charles L. Spurr, Sterchi Jm, Rosenbaum Dl, Tony R. Long, Castle Mc, Wells Hb, Don V. Jackson
Publikováno v:
Cancer chemotherapy and pharmacology. 10(3)
A major drawback of infusions of the vinca alkaloids is the lengthy period of hospitalization which is often required for this novel technique of cancer therapy. A potentially useful system to deliver outpatient therapy has been investigated in a pre
Autor:
Julia M. Cruz, Douglas R. White, James N. Atkins, Wells Hb, Don V. Jackson, Patricia J. Zekan, F I I Richards, Hyman B. Muss
Publikováno v:
The American journal of medicine. 84(6)
Neurotoxicity is the principal limiting side effect of the widely used antitumor agent, vincristine. Following evaluation of glutamic acid as a potential modifier of vincristine toxicity in preclinical studies in mice and a preliminary clinical trial
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.